Lots of great news around the corner, this may be the big year...

Lots of great news around the corner, this may be the big year where we hit 120-130000 licences. Still doesn’t break us even but with USA under the belt the only hold up will be implementing them. I believe there will be a exponential rise once USA provide a clearance. With there partners reselling and implementing for us it should also cut costs of setting up additional resources for Nth America.
The UK is seeing 150%growth and that should continue, overtaking ANZ by year end. It seems that PD is pushing hard on implementation at present which should in turn create additional revenue, giving us the all important cash flow for expansion. Soon enough the tables will turn and Painchek will be the ones being approached, rather than employing reps to sell it.
The hard yards will have been done, with Japan, Germany, and many other large markets ready to bring online.
This is a steady build up to a massive expansion. CR is of course a necessity to fund the future and ready us for what’s coming. This small CR is obviously based on getting us thru the FDA submission, at which case proving successful the share price will of course increase at which time another CR will occur to fund additional expansion, because once FDA approval is received it will open many more doors.
Well done Painchek. Keep up the good work.
Cheers
DYOR . All imo.